EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

From Molecular Mechanisms to Management: Advances in Diabetic Retinopathy and Diabetic Macular Edema

Yenlik Baiturova, Antonio Sarria-Santamera, Yuliya Semenova

International Journal of Molecular Sciences · 16.11.2026 · 27 (22) · 10290

DOI: 10.3390/ijms272210290 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 16.11.2026. Verfasst von Yenlik Baiturova und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic retinopathy (DR) is a major microvascular complication of diabetes mellitus (DM) and a leading cause of vision loss worldwide. Several risk factors have been implicated in the development and progression of DR, such as longer duration of diabetes, poor glycemic control, hypertension, dyslipidemia, renal impairment, and smoking. Diabetic macular edema is the main cause of visual impairment in patients with diabetic retinopathy. It is defined by retinal thickening from fluid leakage into the retina and can be visualized with optical coherence tomography (OCT). At the molecular level, chronic hyperglycemia triggers several pathogenic mechanisms, including oxidative stress, inflammation, advanced glycation end product formation, protein kinase C activation, and dysregulated vascular endothelial growth factor (VEGF) signaling, leading to blood–retinal barrier breakdown, microvascular dysfunction, and retinal neurodegeneration. Current therapeutic approaches include laser photocoagulation, intravitreal anti-VEGF agents, and corticosteroids, with ongoing research into novel interventions targeting senolytic agents, integrin antagonists, inhibitors of vascular adhesion protein-1, anti-inflammatory therapies targeting interleukin-6 (IL-6) signaling, and plasma kallikrein inhibitors. This review synthesizes the recent evidence on DR epidemiology, risk factors, pathophysiology, and treatment, highlighting the need for comprehensive risk-based screening and multidisciplinary management to mitigate the growing burden of diabetic eye disease.

Zitieren

APA

Baiturova, Y., Sarria-Santamera, A., & Semenova, Y. (2026). From Molecular Mechanisms to Management: Advances in Diabetic Retinopathy and Diabetic Macular Edema. International Journal of Molecular Sciences, 27(22), 10290. https://doi.org/10.3390/ijms272210290

Vancouver

Baiturova Y, Sarria-Santamera A, Semenova Y. From Molecular Mechanisms to Management: Advances in Diabetic Retinopathy and Diabetic Macular Edema. International Journal of Molecular Sciences. 2026;27(22):10290. doi:10.3390/ijms272210290

BibTeX
@article{Baiturova2026,
  author = {Baiturova, Yenlik and Sarria-Santamera, Antonio and Semenova, Yuliya},
  title = {From Molecular Mechanisms to Management: Advances in Diabetic Retinopathy and Diabetic Macular Edema},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {22},
  pages = {10290},
  doi = {10.3390/ijms272210290}
}
Kostenlos starten →